Table Of Contents

1. Introduction

1.1 Market Definition & Scope

1.2 Research Assumptions & Abbreviations

1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Therapy Type

  2.3.2 Market Size By Service Type

  2.3.3 Market Size By Vector Type

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

     4.1 Adoption & Deployment Metrics

4.1.1 Percentage of enterprises outsourcing CGT manufacturing for core vs. experimental programs

4.1.2 Growth rate of CDMO adoption across cell therapy, gene therapy, and gene-modified cell therapy

4.1.3 Number of organizations engaging CGT CDMOs annually

     4.2 Technology & Manufacturing Trends

4.2.1 Share of viral vs. non-viral vs. cell-based delivery manufacturing

4.2.2 Adoption of automated, closed-system, and single-use platforms

4.2.3 CDMO service adoption by development stage

     4.3 Performance, Cost & Compliance Statistics

4.3.1 Improvement in manufacturing efficiency and batch success rates

4.3.2 Share of programs meeting GMP and regulatory standards

4.3.3 Cost impact of outsourcing vs. in-house manufacturing

     4.4 Enterprise Usage & Value Creation Insights

4.4.1 CGT programs supported per CDMO facility annually

4.4.2 Use of customized, therapy-specific manufacturing solutions

4.4.3 Sponsor satisfaction, ROI, and partnership retention

5. Cell and Gene Therapy CDMO Market Segmental Analysis & Forecast, By Therapy Type, 2022 – 2035, Value (USD Billion)

5.1 Introduction

 5.2 Cell Therapy

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Gene Therapy

 5.4 Gene-Modified Cell Therapy

6. Cell and Gene Therapy CDMO Market Segmental Analysis & Forecast, By Service Type, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

 6.2 Process & Analytical Development

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

 6.3 Manufacturing (Cell Processing & Vector Production)

 6.4 Fill & Finish Services

7. Cell and Gene Therapy CDMO Market Segmental Analysis & Forecast, By Vector Type, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

 7.2 Viral Vectors

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Non-Viral Vectors

 7.4 Cell-Based Delivery Systems

8. Cell and Gene Therapy CDMO Market Segmental Analysis & Forecast, By End User, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Biopharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

 8.3 Startups

 8.4 Academic & Research Institutes

9. Cell and Gene Therapy CDMO Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Cell and Gene Therapy CDMO Market Size & Forecast, By Therapy Type, 2022 – 2035

 9.2.3 Cell and Gene Therapy CDMO Market Size & Forecast, By Service Type, 2022 – 2035

 9.2.4 Cell and Gene Therapy CDMO Market Size & Forecast, By Vector Type, 2022 – 2035

 9.2.5 Cell and Gene Therapy CDMO Market Size & Forecast, By End User, 2022 – 2035

 9.2.6 Cell and Gene Therapy CDMO Market Size & Forecast, By Country, 2022 – 2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Cell and Gene Therapy CDMO Market Size & Forecast, By Therapy Type, 2022 – 2035

 9.3.3 Cell and Gene Therapy CDMO Market Size & Forecast, By Service Type, 2022 – 2035

 9.3.4 Cell and Gene Therapy CDMO Market Size & Forecast, By Vector Type, 2022 – 2035

 9.3.5 Cell and Gene Therapy CDMO Market Size & Forecast, By End User, 2022 – 2035

 9.3.6 Cell and Gene Therapy CDMO Market Size & Forecast, By Country, 2022 – 2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Cell and Gene Therapy CDMO Market Size & Forecast, By Therapy Type, 2022 – 2035

 9.4.3 Cell and Gene Therapy CDMO Market Size & Forecast, By Service Type, 2022 – 2035

 9.4.4 Cell and Gene Therapy CDMO Market Size & Forecast, By Vector Type, 2022 – 2035

 9.4.5 Cell and Gene Therapy CDMO Market Size & Forecast, By End User, 2022 – 2035

 9.4.6 Cell and Gene Therapy CDMO Market Size & Forecast, By Country, 2022 – 2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Cell and Gene Therapy CDMO Market Size & Forecast, By Therapy Type, 2022 – 2035

 9.5.3 Cell and Gene Therapy CDMO Market Size & Forecast, By Service Type, 2022 – 2035

 9.5.4 Cell and Gene Therapy CDMO Market Size & Forecast, By Vector Type, 2022 – 2035

 9.5.5 Cell and Gene Therapy CDMO Market Size & Forecast, By End User, 2022 – 2035

 9.5.6 Cell and Gene Therapy CDMO Market Size & Forecast, By Country, 2022 – 2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Cell and Gene Therapy CDMO Market Size & Forecast, By Therapy Type, 2022 – 2035

 9.6.3 Cell and Gene Therapy CDMO Market Size & Forecast, By Service Type, 2022 – 2035

 9.6.4 Cell and Gene Therapy CDMO Market Size & Forecast, By Vector Type, 2022 – 2035

 9.6.5 Cell and Gene Therapy CDMO Market Size & Forecast, By End User, 2022 – 2035

 9.6.6 Cell and Gene Therapy CDMO Market Size & Forecast, By Country, 2022 – 2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022 – 2035

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Lonza Group

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Catalent, Inc.

 10.6.3 Thermo Fisher Scientific

 10.6.4 WuXi Advanced Therapies

 10.6.5 Samsung Biologics

 10.6.6 Charles River Laboratories

 10.6.7 AGC Biologics

 10.6.8 Oxford Biomedica

 10.6.9 Fujifilm Diosynth Biotechnologies

 10.6.10 Viralgen Vector Core

 10.6.11 Kite Pharma Manufacturing

 10.6.12 Resilience

 10.6.13 Bayer Cell Therapy Manufacturing

 10.6.14 Yposkesi

 10.6.15 KBI Biopharma

 10.6.16 Brammer Bio

 10.6.17 Cobra Biologics

 10.6.18 Cell and Gene Therapy Catapult Manufacturing Innovation Centre

 10.6.19 Porton Advanced Solutions

 10.6.20 Novasep

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures